{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:33:28Z","timestamp":1781724808485,"version":"3.54.5"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,4,20]],"date-time":"2013-04-20T00:00:00Z","timestamp":1366416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s40257-013-0022-z","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T11:22:16Z","timestamp":1366370536000},"page":"223-233","source":"Crossref","is-referenced-by-count":51,"title":["Penicillamine Revisited: Historic Overview and Review of the Clinical Uses and Cutaneous Adverse Effects"],"prefix":"10.1007","volume":"14","author":[{"given":"Rim","family":"Ishak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ossama","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,20]]},"reference":[{"issue":"4","key":"22_CR1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0002-9343(56)90066-3","volume":"21","author":"JM Walshe","year":"1956","unstructured":"Walshe JM. Penicillamine, a new oral therapy for Wilson\u2019s disease. Am J Med. 1956;21(4):487\u201395.","journal-title":"Am J Med"},{"key":"22_CR2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/151107a0","volume":"151","author":"EPC Abraham","year":"1943","unstructured":"Abraham EPC, Baker W, Robinson R. Penicillamine, a characteristic degradation product of penicillin. Nature. 1943;151:107\u201310.","journal-title":"Nature"},{"issue":"5","key":"22_CR3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/anie.197503301","volume":"14","author":"WM Weigert","year":"1975","unstructured":"Weigert WM, Offermanns H, Scherberich P. d-Penicillamine: production and properties. Angew Chem Int Ed Engl. 1975;14(5):330\u20136.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"22_CR4","first-page":"90","volume":"10","author":"WR Kukovetz","year":"1983","unstructured":"Kukovetz WR, Beubler E, Kreuzig F, et al. Bioavailability and pharmacokinetics of d-penicillamine. J Rheumatol. 1983;10(1):90\u20134.","journal-title":"J Rheumatol"},{"issue":"5","key":"22_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00003088-198713050-00003","volume":"13","author":"P Netter","year":"1987","unstructured":"Netter P, Bannwarth B, Pere P, et al. Clinical pharmacokinetics of d-penicillamine. Clin Pharmacokinet. 1987;13(5):317\u201333.","journal-title":"Clin Pharmacokinet"},{"key":"22_CR6","unstructured":"Perrett D. The metabolism and pharmacology of d-penicillamine in man. J Rheumatol. Suppl. 1981;7:41\u201350."},{"issue":"4","key":"22_CR7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1248\/yakushi1947.102.4_322","volume":"102","author":"K Kyogoku","year":"1982","unstructured":"Kyogoku K, Inoue K, Otake T, et al. Determination of d-penicillamine and its metabolites in blood and urine. Yakugaku Zasshi. 1982;102(4):322\u20137.","journal-title":"Yakugaku Zasshi"},{"issue":"2","key":"22_CR8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00498258809041659","volume":"18","author":"RH Waring","year":"1988","unstructured":"Waring RH, Mitchell SC. The metabolism of 35S-d-penicillamine in man. Xenobiotica. 1988;18(2):235\u201344.","journal-title":"Xenobiotica"},{"issue":"5 Pt 1","key":"22_CR9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0190-9622(96)90729-X","volume":"35","author":"A Bialy-Golan","year":"1996","unstructured":"Bialy-Golan A, Brenner S. Penicillamine-induced bullous dermatoses. J Am Acad Dermatol. 1996;35(5 Pt 1):732\u201342.","journal-title":"J Am Acad Dermatol"},{"key":"22_CR10","unstructured":"Capell HA Madhok R, Zoma A, et al. Is determination of sulfoxidation status a useful predictor of penicillamine toxicity in RA patients? Proceedings of the third world conference on clinical pharmacology and therapeutics; 1986 Jul\u2013Aug; Stockholm: abstract no. 658."},{"issue":"4","key":"22_CR11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0190-9622(83)70062-9","volume":"8","author":"RS Levy","year":"1983","unstructured":"Levy RS, Fisher M, Alter JN. Penicillamine: review and cutaneous manifestations. J Am Acad Dermatol. 1983;8(4):548\u201358.","journal-title":"J Am Acad Dermatol"},{"key":"22_CR12","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(57)92006-8","volume":"2","author":"JE Boulding","year":"1957","unstructured":"Boulding JE, Baker RA. The treatment of metal poisoning with penicillamine. Lancet. 1957;2:985.","journal-title":"Lancet"},{"issue":"5","key":"22_CR13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-2133.2008.08452.x","volume":"158","author":"CT Derk","year":"2008","unstructured":"Derk CT, Huaman G, Jimenez SA. A retrospective randomly selected cohort study of d-penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset. Br J Dermatol. 2008;158(5):1063\u20138.","journal-title":"Br J Dermatol"},{"issue":"8016","key":"22_CR14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(77)92778-7","volume":"1","author":"S Jain","year":"1977","unstructured":"Jain S, Scheuer PJ, Samourian S, et al. A controlled trial of d-penicillamine therapy in primary biliary cirrhosis. Lancet. 1977;1(8016):831\u20134.","journal-title":"Lancet"},{"key":"22_CR15","doi-asserted-by":"crossref","unstructured":"Phelps DL, Lakatos L, Watts JL. d-Penicillamine for preventing retinopathy of prematurity in preterm infants. Cochrane Database Syst Rev. 2001;(1):CD001073.","DOI":"10.1002\/14651858.CD001073"},{"issue":"9","key":"22_CR16","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1651-2227.2010.01837.x","volume":"99","author":"M Tandon","year":"2010","unstructured":"Tandon M, Dutta S, Dogra MR, et al. Oral d-penicillamine for the prevention of retinopathy of prematurity in very low birth weight infants, a randomized placebo controlled trial. Acta Pediatrica. 2010;99(9):1324\u20138.","journal-title":"Acta Pediatrica"},{"key":"22_CR17","doi-asserted-by":"crossref","unstructured":"Klingenberg SL, Chen W. d-penicillamine for primary sclerosing cholangitis. Cochrane Database Syst Rev. 2006;(1):CD004182.","DOI":"10.1002\/14651858.CD004182.pub3"},{"issue":"1","key":"22_CR18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2133.1981.tb00887.x","volume":"105","author":"BJ Mayou","year":"1981","unstructured":"Mayou BJ. d-Penicillamine in the treatment of keloids. Br J Dermatol. 1981;105(1):87\u20139.","journal-title":"Br J Dermatol"},{"issue":"7477","key":"22_CR19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(66)92084-8","volume":"2","author":"WE Beer","year":"1966","unstructured":"Beer WE, Lyle WH. Penicillamine for the treatment of Darier\u2019s disease and other disorders of keratin formation. Lancet. 1966;2(7477):1337\u201340.","journal-title":"Lancet"},{"issue":"5","key":"22_CR20","first-page":"471","volume":"61","author":"A Savage","year":"1980","unstructured":"Savage A, Hinton C, Tribe CR. Experimental murine amyloidosis II: effect of penicillamine therapy. Br J Exp Pathol. 1980;61(5):471\u20133.","journal-title":"Br J Exp Pathol"},{"issue":"1","key":"22_CR21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2516.2003.00676.x","volume":"9","author":"JJ Corrigan Jr","year":"2003","unstructured":"Corrigan JJ Jr, Damiano ML, Leissinger C, et al. Treatment of chronic haemophilic synovitis in humans with d-penicillamine. Haemophilia. 2003;9(1):64\u20138.","journal-title":"Haemophilia"},{"key":"22_CR22","doi-asserted-by":"crossref","unstructured":"Kaya TI, Kokturk A, Tursen U, et al. d-Penicillamine treatment for lipoid proteinosis. Pediatr Dermatol. 2002;19(4):359\u201362.","DOI":"10.1046\/j.1525-1470.2002.00104.x"},{"issue":"1","key":"22_CR23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000287967","volume":"78","author":"R Nagler","year":"2010","unstructured":"Nagler R, Cohen S, Savulescu D, et al. Penicillamine as a potent protector against injurious effects of cigarette smoke in aerodigestive tract cancer. Oncology. 2010;78(1):12\u20139.","journal-title":"Oncology"},{"issue":"5","key":"22_CR24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/107327489900600502","volume":"6","author":"S Brem","year":"1999","unstructured":"Brem S. Angiogenesis and cancer control: from concept to therapeutic trial. Cancer Control. 1999;6(5):436\u201358.","journal-title":"Cancer Control"},{"issue":"1","key":"22_CR25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ctrv.2008.07.004","volume":"35","author":"A Gupte","year":"2009","unstructured":"Gupte A, Mumper RJ. Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev. 2009;35(1):32\u201346.","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"22_CR26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1215\/S1152851704000869","volume":"7","author":"S Brem","year":"2005","unstructured":"Brem S, Grossman SA, Carson KA, et al. Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma. Neuro Oncol. 2005;7(3):246\u201353.","journal-title":"Neuro Oncol"},{"issue":"1","key":"22_CR27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2362.2002.00933.x","volume":"32","author":"R Squitti","year":"2002","unstructured":"Squitti R, Rossini PM, Cassetta E, et al. d-Penicillamine reduces serum oxidative stress in Alzheimer\u2019s disease patients. Eur J Clin Invest. 2002;32(1):51\u20139.","journal-title":"Eur J Clin Invest"},{"issue":"7471","key":"22_CR28","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0140-6736(66)92926-6","volume":"2","author":"ED Harris Jr","year":"1966","unstructured":"Harris ED Jr, Sjoerdsma A. Effect of penicillamine on human collagen and its possible application to treatment of scleroderma. Lancet. 1966;2(7471):996\u20139.","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"22_CR29","first-page":"65","volume":"70","author":"ME Nimni","year":"1977","unstructured":"Nimni ME. Mechanism of inhibition of collagen crosslinking by penicillamine. Proc R Soc Med. 1977;70(Suppl. 3):65\u201372.","journal-title":"Proc R Soc Med"},{"issue":"5","key":"22_CR30","doi-asserted-by":"crossref","first-page":"652","DOI":"10.7326\/0003-4819-97-5-652","volume":"97","author":"VD Steen","year":"1982","unstructured":"Steen VD, Medsger TA Jr, Rodnan GP. d-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis. Ann Intern Med. 1982;97(5):652\u20139.","journal-title":"Ann Intern Med"},{"issue":"10","key":"22_CR31","first-page":"1496","volume":"18","author":"SA Jimenez","year":"1991","unstructured":"Jimenez SA, Sigal SH. A 15-year prospective study of treatment of rapidly progressive systemic sclerosis with d-penicillamine. J Rheumatol. 1991;18(10):1496\u2013503.","journal-title":"J Rheumatol"},{"key":"22_CR32","unstructured":"Rodnan GP. Progressive systemic sclerosis and penicillamine. J Rheumatol Suppl. 1981;7:116\u201320."},{"issue":"12","key":"22_CR33","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U","volume":"44","author":"VD Steen","year":"2001","unstructured":"Steen VD, Medsger TA Jr. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum. 2001;44(12):2828\u201335.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"22_CR34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/030097401316909503","volume":"30","author":"TA Medsger Jr","year":"2001","unstructured":"Medsger TA Jr, Lucas M, Wildy KS, et al. d-Penicillamine in systemic sclerosis? Yes! Scand J Rheumatol. 2001;30(4):192\u20134.","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"22_CR35","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","volume":"43","author":"PJ Clements","year":"2000","unstructured":"Clements PJ, Hurwitz EL, Wong WK, et al. Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial. Arthritis Rheum. 2000;43(11):2445\u201354.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"22_CR36","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7","volume":"42","author":"PJ Clements","year":"1999","unstructured":"Clements PJ, Furst DE, Wong WK, et al. High-dose versus low-dose d-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum. 1999;42(6):1194\u2013203.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"22_CR37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.1990.01670290053007","volume":"126","author":"V Falanga","year":"1990","unstructured":"Falanga V, Medsger TA Jr. d-Penicillamine in the treatment of localized scleroderma. Arch Dermatol. 1990;126(5):609\u201312.","journal-title":"Arch Dermatol"},{"issue":"7800","key":"22_CR38","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(73)90287-0","volume":"I","author":"EJ Moynahan","year":"1973","unstructured":"Moynahan EJ. d(-)Penicillamine in morphoea (localised scleroderma). Lancet. 1973;I(7800):428\u20139.","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"22_CR39","first-page":"39","volume":"50","author":"M Tandon","year":"1974","unstructured":"Tandon M, Dutta S, Dogra MR. Penicillamine in the treatment of morphoea and keloid in children. Postgrad Med J. 1974;50(Suppl. 2):39\u201341.","journal-title":"Postgrad Med J"},{"issue":"2","key":"22_CR40","first-page":"51","volume":"20","author":"M Sharifian","year":"2011","unstructured":"Sharifian M, Sari-Aslani F, Hemmatinejad B, et al. d-Penicillamine, a potent melanogenesis inhibitor, lacks any depigmenting effect on black guinea pig skin: the first randomized, evaluated blinded vehicle-controlled, in vivo study. Acta Dermatoven APA. 2011;20(2):51\u20133.","journal-title":"Acta Dermatoven APA"},{"key":"22_CR41","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/ijc.23664","volume":"123","author":"AA Brozyna","year":"2008","unstructured":"Brozyna AA, VanMiddlesworth L, Slomiski AT. Inhibition of melanogenesis as a radiation senstitizer for melanoma therapy. Int J Cancer. 2008;123:1448\u201356.","journal-title":"Int J Cancer"},{"issue":"10","key":"22_CR42","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10495-012-0746-x","volume":"17","author":"S Qiao","year":"2012","unstructured":"Qiao S, Cabello C, Lamore SD, et al. d-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis. 2012;17(10):1079\u201394.","journal-title":"Apoptosis"},{"issue":"3","key":"22_CR43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0049-0172(89)90027-9","volume":"19","author":"MW Grisanti","year":"1989","unstructured":"Grisanti MW, Moore TL, Osborn TG, et al. Eosinophilic fasciitis in children. Semin Arthritis Rheum. 1989;19(3):151\u20137.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"22_CR44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/rheumatology\/21.4.218","volume":"21","author":"D Caspi","year":"1982","unstructured":"Caspi D, Fishel R, Varon M, et al. Multisystem presentation of eosinophilic fasciitis. Rheumatol Rehabil. 1982;21(4):218\u201321.","journal-title":"Rheumatol Rehabil"},{"issue":"2","key":"22_CR45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0049-0172(91)90044-Z","volume":"21","author":"P Mart\u00ednez-Osuna","year":"1991","unstructured":"Mart\u00ednez-Osuna P, Wallach PM, Seleznick MJ, et al. Treatment of the eosinophilia-myalgia syndrome. Semin Arthritis Rheum. 1991;21(2):110\u201321.","journal-title":"Semin Arthritis Rheum"},{"key":"22_CR46","unstructured":"Stork J, N\u0115mcov\u00e1 D, Hoza J, et al. Eosinophilic fasciitis in an adolescent girl with lymphadenopathy and vitiligo-like and linear scleroderma-like changes: a case report. Clin Exp Rheumatol. 1996;14(3):337\u201341."},{"issue":"1","key":"22_CR47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-4632.2007.03544.x","volume":"47","author":"L Bischoff","year":"2008","unstructured":"Bischoff L, Derk CT. Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol. 2008;47(1):29\u201335.","journal-title":"Int J Dermatol"},{"issue":"6","key":"22_CR48","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1001\/jama.1979.03300060030023","volume":"242","author":"GR Epler","year":"1979","unstructured":"Epler GR, Snider GL, Gaensler EA, et al. Bronchiolitis and bronchitis in connective tissue disease: a possible relationship to the use of penicillamine. JAMA. 1979;242(6):528\u201332.","journal-title":"JAMA"},{"key":"22_CR49","first-page":"13","volume":"12","author":"VM Kovalev","year":"1989","unstructured":"Kovalev VM, Krivenko ZF. New aspects of the pathogenesis and treatment of Schulmann\u2019s eosinophilic fasciitis. Vestn Dermatol Venerol. 1989;12:13\u20135.","journal-title":"Vestn Dermatol Venerol"},{"issue":"1","key":"22_CR50","first-page":"128","volume":"20","author":"ML Farrington","year":"1993","unstructured":"Farrington ML, Haas JE, Nazar-Stewart V, et al. Eosinophilic fasciitis in children frequently progresses to scleroderma-like cutaneous fibrosis. J Rheumatol. 1993;20(1):128\u201332.","journal-title":"J Rheumatol"},{"issue":"2","key":"22_CR51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2340\/0001555560181182","volume":"60","author":"HE Coyle","year":"1980","unstructured":"Coyle HE, Chapman RS. Eosinophilic fasciitis (Shulman syndrome) in association with morphoea and systemic sclerosis. Acta Derm Venereol. 1980;60(2):181\u20132.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"22_CR52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10067-011-1866-3","volume":"31","author":"CU Manzini","year":"2012","unstructured":"Manzini CU, Sebastiani M, Giuggioli D, et al. d-Penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. Clin Rheumatol. 2012;31(1):183\u20137.","journal-title":"Clin Rheumatol"},{"key":"22_CR53","doi-asserted-by":"crossref","unstructured":"Shiokawa Y, Horiuchi Y, Honma M, et al. Clinical evaluation of d-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis. Arthritis Rheum. 1977; 20 (8):1464\u201372.","DOI":"10.1002\/art.1780200804"},{"issue":"6375","key":"22_CR54","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bmj.286.6375.1442-a","volume":"286","author":"MI Garlepp","year":"1983","unstructured":"Garlepp MI, Dawkins RL, Christiansen FT. HLA antigens and acetylcholine receptor antibodies in penicillamine induced myasthenia gravis. Br Med J (Clin Res Ed). 1983;286(6375):1442\u20133.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"5","key":"22_CR55","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/ard.42.5.500","volume":"42","author":"JP Delamere","year":"1983","unstructured":"Delamere JP, Jobson S, Mackintosh LP, et al. Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features. Ann Rheum Dis. 1983;42(5):500\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"22_CR56","first-page":"269","volume":"13","author":"A Stockman","year":"1986","unstructured":"Stockman A, Zilko PJ, Major GA, et al. Genetic markers in rheumatoid arthritis relationship to toxicity from d-penicillamine. J Rheumato. 1986;13(2):269\u201373.","journal-title":"J Rheumato"},{"issue":"Suppl. 2","key":"22_CR57","first-page":"73","volume":"50","author":"ED Bird","year":"1974","unstructured":"Bird ED. Aplastic anaemia following penicillamine. Postgrad Med J. 1974;50(Suppl. 2):73\u20134.","journal-title":"Postgrad Med J"},{"issue":"12","key":"22_CR58","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1111\/j.1572-0241.1998.00715.x","volume":"93","author":"CG Siafakas","year":"1998","unstructured":"Siafakas CG, Jonas MM, Alexander S, et al. Early onset of nephrotic syndrome after treatment with d-penicillamine in a patient with Wilson\u2019s disease. Am J Gastroenterol. 1998;93(12):2544\u20136.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"22_CR59","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.ajkd.2007.05.026","volume":"50","author":"F Bienaime","year":"2007","unstructured":"Bienaime F, Clerbaux G, Plaisier E, et al. d-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease. Am J Kidney Dis. 2007;50(5):821\u20135.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"22_CR60","first-page":"1616","volume":"30","author":"CT Derk","year":"2003","unstructured":"Derk CT, Jimenez SA. Goodpasture-like syndrome induced by d-penicillamine in a patient with systemic sclerosis: report and review of the literature. J Rheumatol. 2003;30(7):1616\u201320.","journal-title":"J Rheumatol"},{"key":"22_CR61","doi-asserted-by":"crossref","unstructured":"Sharma R, Jain S, Kher V. ANCA-associated Goodpastures syndrome in a patient with rheumatoid arthritis on penicillamine. Indian J Nephrol. 2012; 22(1):45\u201347.","DOI":"10.4103\/0971-4065.83743"},{"key":"22_CR62","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF02207960","volume":"11","author":"RN DeSilva","year":"1992","unstructured":"DeSilva RN, Eastmond CJ. Management of proteinuria secondary to penicillamine therapy in rheumatoid arthritis. Clin Rheumatol. 1992;11:216\u20139.","journal-title":"Clin Rheumatol"},{"key":"22_CR63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/rheumatology\/25.2.193","volume":"25","author":"A Kay","year":"1986","unstructured":"Kay A. European league against rheumatism study of adverse reactions to d-penicillamine. Br J Rheumatol. 1986;25:193\u20138.","journal-title":"Br J Rheumatol"},{"key":"22_CR64","first-page":"661","volume":"80","author":"PA Bacon","year":"1976","unstructured":"Bacon PA, Tribe CR, Mackenzie JC, et al. Penicillamine nephropathy in rheumatoid arthritis. QJM. 1976;80:661\u201384.","journal-title":"QJM"},{"issue":"5","key":"22_CR65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejim.2006.03.001","volume":"17","author":"GS Habib","year":"2006","unstructured":"Habib GS, Saliba W, Nashashibi M, et al. Penicillamine and nephrotic syndrome. Eur J Intern Med. 2006;17(5):343\u20138.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"22_CR66","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/rheumatology\/23.3.220","volume":"23","author":"SP Shettar","year":"1984","unstructured":"Shettar SP, Chattopadhyay C, Wolstenholme RJ, et al. Diffuse alveolitis on a small dose of penicillamine. Br J Rheumatol. 1984;23(3):220\u20134.","journal-title":"Br J Rheumatol"},{"issue":"1","key":"22_CR67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0022-510X(96)00265-1","volume":"146","author":"Y Kato","year":"1997","unstructured":"Kato Y, Naito Y, Narita Y, et al. d-Penicillamine-induced myasthenia gravis in a case of eosinophilic fasciitis. J Neurol Sci. 1997;146(1):85\u20136.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"22_CR68","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2012.05.011","volume":"250","author":"K Poulas","year":"2012","unstructured":"Poulas K, Koutsouraki E, Kordas G, et al. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine. J Neuroimmunol. 2012;250(1\u20132):94\u20138.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"22_CR69","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1345\/aph.1A229","volume":"36","author":"JZ Tchebiner","year":"2002","unstructured":"Tchebiner JZ. Breast enlargement induced by d-penicillamine. Ann Pharmacother. 2002;36(3):444\u20135.","journal-title":"Ann Pharmacother"},{"key":"22_CR70","unstructured":"Bertrand JL, Rousset H, Queneau P, et al. Autoimmune thyroiditis: a rare complication of treatment with d-penicillamine (author\u2019s transl). Therapie. 1981;36(3):333\u20136."},{"issue":"1","key":"22_CR71","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF02231694","volume":"15","author":"R Chappel","year":"1996","unstructured":"Chappel R, Willems J. d-Penicillamine-induced myositis in rheumatoid arthritis. Clin Rheumatol. 1996;15(1):86\u20137.","journal-title":"Clin Rheumatol"},{"key":"22_CR72","doi-asserted-by":"crossref","unstructured":"Herrero JL, Mu\u00f1oz Bertr\u00e1n E, Ortega Gonz\u00e1lez I, et al. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson\u2019s disease. Gastroenterol Hepatol. 2012;35(10):704\u20137.","DOI":"10.1016\/j.gastrohep.2012.03.008"},{"issue":"5","key":"22_CR73","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archderm.1973.01620260061026","volume":"108","author":"F Pass","year":"1973","unstructured":"Pass F, Goldfischer S, Sternlieb I, et al. Elastosis perforans serpiginosa during penicillamine therapy for Wilson disease. Arch Dermatol. 1973;108(5):713\u20135.","journal-title":"Arch Dermatol"},{"issue":"1","key":"22_CR74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000247491","volume":"184","author":"JL Bolognia","year":"1992","unstructured":"Bolognia JL, Braverman I. Pseudoxanthoma-elasticum-like skin changes induced by penicillamine. Dermatology. 1992;184(1):12\u20138.","journal-title":"Dermatology"},{"issue":"9","key":"22_CR75","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archderm.1976.01630330029007","volume":"112","author":"KE Greer","year":"1976","unstructured":"Greer KE, Askew FC, Richardson DR. Skin lesions induced by penicillamine: occurrence in a patient with hepatolenticular degeneration (Wilson disease). Arch Dermatol. 1976;112(9):1267\u20139.","journal-title":"Arch Dermatol"},{"key":"22_CR76","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/archderm.1977.01640070110019","volume":"113","author":"W Davis","year":"1977","unstructured":"Davis W. Wilson\u2019s disease and penicillamine-induced anetoderma. Arch Dermatol. 1977;113:976.","journal-title":"Arch Dermatol"},{"issue":"4","key":"22_CR77","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2230.1988.tb00693.x","volume":"13","author":"S Burge","year":"1988","unstructured":"Burge S, Ryan T. Penicillamine-induced pseudo-pseudoxanthoma elasticum in a patient with rheumatoid arthritis. Clin Exp Dermatol. 1988;13(4):255\u20138.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"22_CR78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/jcp.51.2.169","volume":"51","author":"AP Coatesworth","year":"1998","unstructured":"Coatesworth AP, Darnton SJ, Green RM, et al. A case of systemic pseudo-pseudoxanthoma elasticum with diverse symptomatology caused by long-term penicillamine use. J Clin Pathol. 1998;51(2):169\u201371.","journal-title":"J Clin Pathol"},{"issue":"4","key":"22_CR79","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaad.2008.09.018","volume":"60","author":"BK Lewis","year":"2009","unstructured":"Lewis BK, Chern PL, Stone MS. Penicillamine-induced elastosis of the mucosal lip. J Am Acad Dermatol. 2009;60(4):700\u20133.","journal-title":"J Am Acad Dermatol"},{"key":"22_CR80","doi-asserted-by":"crossref","unstructured":"Rath N, Bhardwaj A, Kar HK, et al. Penicillamine induced pseudoxanthoma elasticum with elastosis perforans serpiginosa. Indian J Dermatol Venereol Leprol. 2005;71(3):182\u20135.","DOI":"10.4103\/0378-6323.16234"},{"issue":"1","key":"22_CR81","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000081487","volume":"210","author":"C Becuwe","year":"2005","unstructured":"Becuwe C, Dalle S, Ronger-Savle S, et al. Elastosis perforans serpiginosa associated with pseudo-pseudoxanthoma elasticum during treatment of Wilson\u2019s disease with penicillamine. Dermatology. 2005;210(1):60\u20133.","journal-title":"Dermatology"},{"key":"22_CR82","doi-asserted-by":"crossref","unstructured":"Meyrick Thomas RH, Kirby JD. Elastosis perforans serpiginosa and pseudoxanthoma elasticum-like skin change due to d-penicillamine. Clin Exp Dermatol. 1985;10(4):386\u201391.","DOI":"10.1111\/j.1365-2230.1985.tb00588.x"},{"issue":"1","key":"22_CR83","first-page":"49","volume":"76","author":"LB Rosen","year":"2005","unstructured":"Rosen LB, Muellenhoff M, Tran TT, et al. Elastosis perforans serpiginosa secondary to d-penicillamine therapy with coexisting cutis laxa. Cutis. 2005;76(1):49\u201353.","journal-title":"Cutis"},{"issue":"3","key":"22_CR84","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1046\/j.1365-2133.2000.03379.x","volume":"142","author":"VA Hill","year":"2000","unstructured":"Hill VA, Seymour CA, Mortimer PS. Pencillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson\u2019s disease. Br J Dermatol. 2000;142(3):560\u20131.","journal-title":"Br J Dermatol"},{"issue":"8","key":"22_CR85","first-page":"667","volume":"30","author":"B Amichai","year":"1994","unstructured":"Amichai B, Rotem A, Metzker A. d-Penicillamine-induced elastosis perforans serpiginosa and localized cutis laxa in a patient with Wilson\u2019s disease. Isr J Med Sci. 1994;30(8):667\u20139.","journal-title":"Isr J Med Sci"},{"issue":"7","key":"22_CR86","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1346-8138.1997.tb02820.x","volume":"24","author":"K Iozumi","year":"1997","unstructured":"Iozumi K, Nakagawa H, Tamaki K. Penicillamine-induced degenerative dermatoses: report of a case and brief review of such dermatoses. J Dermatol. 1997;24(7):458\u201365.","journal-title":"J Dermatol"},{"issue":"4","key":"22_CR87","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-0560.1979.tb01131.x","volume":"6","author":"H Bardach","year":"1979","unstructured":"Bardach H, Gebhart W, Niebauer G. \u201cLumpy-bumpy\u201d elastic fibers in the skin and lungs of a patient with a penicillamine-induced elastosis perforans serpiginosa. J Cutan Pathol. 1979;6(4):243\u201352.","journal-title":"J Cutan Pathol"},{"issue":"9","key":"22_CR88","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1001\/archderm.1987.01660330034007","volume":"123","author":"R Bergman","year":"1987","unstructured":"Bergman R, Friedman-Birnbaum R, Ludatscher R, et al. An ultrastructural study of the reactive type of elastosis perforans serpiginosa. Arch Dermatol. 1987;123(9):1127\u20139.","journal-title":"Arch Dermatol"},{"issue":"4","key":"22_CR89","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archderm.1968.01610100021003","volume":"97","author":"AH Mehregan","year":"1968","unstructured":"Mehregan AH. Elastosis perforans serpiginosa: a review of the literature and report of 11 cases. Arch Dermatol. 1968;97(4):381\u201393.","journal-title":"Arch Dermatol"},{"key":"22_CR90","doi-asserted-by":"crossref","unstructured":"Price RG, Prentice RS. Penicillamine-induced elastosis perforans serpiginosa: tip of the iceberg? Am J Dermatopathol. 1986;8(4):314\u201320.","DOI":"10.1097\/00000372-198608000-00007"},{"issue":"4","key":"22_CR91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D35TS1V967","volume":"17","author":"L Atzori","year":"2011","unstructured":"Atzori L, Pinna AL, Pau M, et al. d-Penicillamine elastosis perforans serpiginosa: description of two cases and review of the literature. Dermatol Online J. 2011;17(4):3.","journal-title":"Dermatol Online J"},{"issue":"8","key":"22_CR92","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1902\/jop.2010.090736","volume":"81","author":"S Tovaru","year":"2010","unstructured":"Tovaru S, Parlatescu I, Dumitriu AS, et al. Oral complications associated with d-penicillamine treatment for Wilson disease: a clinicopathologic report. J Periodontol. 2010;81(8):1231\u20136.","journal-title":"J Periodontol"},{"issue":"4","key":"22_CR93","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1464-410X.2003.04042.x","volume":"91","author":"MA Roest","year":"2003","unstructured":"Roest MA, Ratnavel R. Elastosis perforans serpiginosa of the penis. BJU Int. 2003;91(4):427.","journal-title":"BJU Int"},{"issue":"2","key":"22_CR94","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/76102","volume":"25","author":"O Saux Le","year":"2000","unstructured":"Le Saux O, Urban Z, Tschuch C, et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet. 2000;25(2):223\u20137.","journal-title":"Nat Genet"},{"issue":"10","key":"22_CR95","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.bjps.2006.01.010","volume":"59","author":"S Rayatt","year":"2006","unstructured":"Rayatt S, Pandey U, Khanna A. Familial pseudo pseudoxanthoma elasticum. J Plast Reconstr Aesthet Surg. 2006;59(10):1127\u20139.","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"22_CR96","doi-asserted-by":"crossref","unstructured":"Meyrick Thomas RH, Light N, Stephens AD, et al. Pseudoxanthoma elasticum-like skin changes induced by penicillamine. J R Soc Med. 1984;77(9):794\u20138.","DOI":"10.1177\/014107688407700917"},{"issue":"8134","key":"22_CR97","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0140-6736(79)90019-9","volume":"2","author":"JM Walshe","year":"1979","unstructured":"Walshe JM. Congenital cutis laxa and maternal d-penicillamine. Lancet. 1979;2(8134):144\u20135.","journal-title":"Lancet"},{"issue":"8132","key":"22_CR98","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(79)90210-1","volume":"2","author":"A Linares","year":"1979","unstructured":"Linares A, Zarranz JJ, Rodriguez-Alarcon J, et al. Reversible cutis laxa due to maternal d-penicillamine treatment. Lancet. 1979;2(8132):43.","journal-title":"Lancet"},{"issue":"3","key":"22_CR99","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ajmg.a.10871","volume":"128A","author":"R Pinter","year":"2004","unstructured":"Pinter R, Hogge WA, McPherson E. Infant with severe penicillamine embryopathy born to a woman with Wilson disease. Am J Med Genet A. 2004;128A(3):294\u20138.","journal-title":"Am J Med Genet A"},{"issue":"19","key":"22_CR100","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1001\/jama.1982.03320440053036","volume":"247","author":"J Zone","year":"1982","unstructured":"Zone J, Ward J, Boyce E, et al. Penicillamine-induced pemphigus. JAMA. 1982;247(19):2705\u20137.","journal-title":"JAMA"},{"key":"22_CR101","unstructured":"Dawkins RL, Zilko PJ, Carrano J, et al. Immunobiology of d-penicillamine. J Rheumatol Suppl. 1981;7:56\u201361."},{"issue":"6","key":"22_CR102","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM197902083000602","volume":"300","author":"O Epstein","year":"1979","unstructured":"Epstein O, De Villiers D, Jain S, et al. Reduction of immune complexes and immunoglobulins induced by d-penicillamine in primary biliary cirrhosis. N Engl J Med. 1979;300(6):274\u20138.","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"22_CR103","first-page":"59","volume":"50","author":"EC Huskisson","year":"1974","unstructured":"Huskisson EC, Berry H. Some immunological changes in rheumatoid arthritis among patients receiving penicillamine and gold. Postgrad Med J. 1974;50(Suppl. 2):59\u201361.","journal-title":"Postgrad Med J"},{"issue":"6","key":"22_CR104","first-page":"751","volume":"76","author":"R Degos","year":"1969","unstructured":"Degos R, Touraine R, Belaich S, et al. Pemphigus in a patient treated with penicillamine for Wilson\u2019s disease. Bull Soc Fr Dermatol Syphiligr. 1969;76(6):751\u20133.","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"issue":"3","key":"22_CR105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0733-8635(18)30243-2","volume":"11","author":"DF Mutasim","year":"1993","unstructured":"Mutasim DF, Pelc NJ, Anhalt GJ. Drug-induced pemphigus. Dermatol Clin. 1993;11(3):463\u201371.","journal-title":"Dermatol Clin"},{"issue":"5","key":"22_CR106","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-4362.1991.tb03867.x","volume":"30","author":"V Ruocco","year":"1991","unstructured":"Ruocco V, Sacerdoti G. Pemphigus and bullous pemphigoid due to drugs. Int J Dermatol. 1991;30(5):307\u201312.","journal-title":"Int J Dermatol"},{"issue":"1","key":"22_CR107","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0190-9622(97)70224-X","volume":"37","author":"PF Penas","year":"1997","unstructured":"Penas PF, Buezo GF, Carvajal I, et al. D-Penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1 in a patient with mixed connective tissue disease. J Am Acad Dermatol. 1997;37(1):121\u20133.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"22_CR108","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1365-2133.1999.03071.x","volume":"141","author":"GG Toth","year":"1999","unstructured":"Toth GG, Jonkman MF. Successful treatment of recalcitrant penicillamine-induced pemphigus foliaceus by low-dose intravenous immunoglobulins. Br J Dermatol. 1999;141(3):583\u20135.","journal-title":"Br J Dermatol"},{"issue":"6","key":"22_CR109","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0190-9622(03)00441-9","volume":"49","author":"P Cetkovska","year":"2003","unstructured":"Cetkovska P, Pizinger K, Skalova A. Epidermolysis bullosa acquisita-like reaction associated with penicillamine therapy for sclerodermatous graft-versus-host disease. J Am Acad Dermatol. 2003;49(6):1157\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"22_CR110","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/00015550410026399","volume":"84","author":"A Szegedi","year":"2004","unstructured":"Szegedi A, Suranyi P, Szucs G, et al. D-Penicillamine-induced pemphigus vulgaris in a patient with scleroderma-rheumatoid arthritis overlap syndrome. Acta Derm Venereol. 2004;84(4):318\u20139.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"22_CR111","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2165\/0128071-200910010-00006","volume":"10","author":"S Popadic","year":"2009","unstructured":"Popadic S, Skiljevic D, Medenica L. Bullous pemphigoid induced by penicillamine in a patient with Wilson disease. Am J Clin Dermatol. 2009;10(1):36\u20138.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"22_CR112","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/09546630410027805","volume":"15","author":"K Sugita","year":"2004","unstructured":"Sugita K, Hirokawa H, Izu K, et al. d-Penicillamine-induced pemphigus successfully treated with combination therapy of mizoribine and prednisolone. J Dermatolog Treat. 2004;15(4):214\u20137.","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"22_CR113","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2133.2001.04043.x","volume":"144","author":"K Ogata","year":"2001","unstructured":"Ogata K, Nakajima H, Ikeda M, et al. Drug-induced pemphigus foliaceus with features of pemphigus vulgaris. Br J Dermatol. 2001;144(2):421\u20132.","journal-title":"Br J Dermatol"},{"issue":"2 Pt 1","key":"22_CR114","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0190-9622(00)90146-4","volume":"42","author":"M Shapiro","year":"2000","unstructured":"Shapiro M, Jimenez S, Werth VP. Pemphigus vulgaris induced by d-penicillamine therapy in a patient with systemic sclerosis. J Am Acad Dermatol. 2000;42(2 Pt 1):297\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"22_CR115","first-page":"153","volume":"126","author":"V Jan","year":"1999","unstructured":"Jan V, Callens A, Machet L, et al. d-Penicillamine-induced pemphigus, polymyositis and myasthenia. Ann Dermatol Venereol. 1999;126(2):153\u20136.","journal-title":"Ann Dermatol Venereol"},{"issue":"6074","key":"22_CR116","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/bmj.1.6074.1473","volume":"1","author":"JS Pegum","year":"1977","unstructured":"Pegum JS, Pembroke AC. Benign mucous-membrane pemphigoid associated with penicillamine treatment. Br Med J. 1977;1(6074):1473.","journal-title":"Br Med J"},{"issue":"3","key":"22_CR117","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-0560.1989.tb00031.x","volume":"16","author":"HB Rasmussen","year":"1989","unstructured":"Rasmussen HB, Jepsen LV, Brandrup F. Penicillamine-induced bullous pemphigoid with pemphigus-like antibodies. J Cutan Pathol. 1989;16(3):154\u20137.","journal-title":"J Cutan Pathol"},{"issue":"12","key":"22_CR118","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1345\/aph.18099","volume":"32","author":"R Weller","year":"1998","unstructured":"Weller R, White MI. Penicillamine in the etiology of bullous pemphigoid. Ann Pharmacother. 1998;32(12):1368.","journal-title":"Ann Pharmacother"},{"issue":"2","key":"22_CR119","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2230.1996.tb00033.x","volume":"21","author":"R Weller","year":"1996","unstructured":"Weller R, White MI. Bullous pemphigoid and penicillamine. Clin Exp Dermatol. 1996;21(2):121\u20132.","journal-title":"Clin Exp Dermatol"},{"key":"22_CR120","doi-asserted-by":"crossref","unstructured":"Brenner S, Bialy-Golan A, Ruocco V. Drug-induced pemphigus. Clin Dermatol. 1998;16(3):393\u20137.","DOI":"10.1016\/S0738-081X(98)00010-8"},{"issue":"6049","key":"22_CR121","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/bmj.2.6049.1423","volume":"2","author":"RA Marsden","year":"1976","unstructured":"Marsden RA, Vanhegan RI, Walshe M, et al. Pemphigus foliaceus induced by penicillamine. Br Med J. 1976;2(6049):1423\u20134.","journal-title":"Br Med J"},{"key":"22_CR122","doi-asserted-by":"crossref","unstructured":"Santa Cruz DJ, Prioleau PG, Marcus MD, et al. Pemphigus-like lesions induced by d-penicillamine: analysis of clinical, histopathological, and immunofluorescence features in 34 cases. Am J Dermatopathol. 1981 Spring;3(1):85\u201392.","DOI":"10.1097\/00000372-198100310-00012"},{"issue":"3","key":"22_CR123","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0030-4220(78)90524-8","volume":"45","author":"KD Hay","year":"1978","unstructured":"Hay KD, Muller HK, Reade PC. d-Penicillamine-induced mucocutaneous lesions with features of pemphigus. Oral Surg Oral Med Oral Pathol. 1978;45(3):385\u201395.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"2","key":"22_CR124","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/1523-1747.ep12464471","volume":"96","author":"NJ Korman","year":"1991","unstructured":"Korman NJ, Eyre RW, Zone J, et al. Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol. 1991;96(2):273\u20136.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"22_CR125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2230.2004.01655.x","volume":"30","author":"K Nagao","year":"2005","unstructured":"Nagao K, Tanikawa A, Yamamoto N, et al. Decline of anti-desmoglein 1 IgG ELISA scores by withdrawal of d-penicillamine in drug-induced pemphigus foliaceus. Clin Exp Dermatol. 2005;30(1):43\u20135.","journal-title":"Clin Exp Dermatol"},{"key":"22_CR126","doi-asserted-by":"crossref","unstructured":"Troy JL, Silvers DN, Grossman ME, et al. Penicillamine-associated pemphigus: is it really pemphigus? J Am Acad Dermatol. 1981;4(5):547\u201355.","DOI":"10.1016\/S0190-9622(81)70055-0"},{"issue":"1","key":"22_CR127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000246749","volume":"189","author":"R Wolf","year":"1994","unstructured":"Wolf R, Brenner S. An active amide group in the molecule of drugs that induce pemphigus: a casual or causal relationship? Dermatology. 1994;189(1):1\u20134.","journal-title":"Dermatology"},{"issue":"9","key":"22_CR128","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archderm.1987.01660330026002","volume":"123","author":"MD Brown","year":"1987","unstructured":"Brown MD, Dubin HV. Penicillamine-induced bullous pemphigoid-like eruption. Arch Dermatol. 1987;123(9):1119\u201320.","journal-title":"Arch Dermatol"},{"key":"22_CR129","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2133.1985.tb13057.x","volume":"113","author":"LR Lever","year":"1985","unstructured":"Lever LR, Wojnarowska F. Benign mucous membrane pemphigoid and penicillamine. Br J Dermatol. 1985;113:88\u20139.","journal-title":"Br J Dermatol"},{"issue":"4","key":"22_CR130","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1365-2230.1985.tb00589.x","volume":"10","author":"D Shuttleworth","year":"1985","unstructured":"Shuttleworth D, Graham-Brown RA, Hutchinson PE, et al. Cicatricial pemphigoid in d-penicillamine treated patients with rheumatoid arthritis: a report of three cases. Clin Exp Dermatol. 1985;10(4):392\u20137.","journal-title":"Clin Exp Dermatol"},{"key":"22_CR131","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2133.1985.tb13058.x","volume":"113","author":"DGBR Shuttleworth","year":"1985","unstructured":"Shuttleworth DGBR. Cicatricial pemphigoid in a d-penicillamine treated patient with rheumatoid arthritis. Br J Dermatol. 1985;113:89\u201390.","journal-title":"Br J Dermatol"},{"issue":"4","key":"22_CR132","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0190-9622(86)80459-5","volume":"14","author":"J Peyri","year":"1986","unstructured":"Peyri J, Servitje O, Ribera M, et al. Cicatricial pemphigoid in a patient with rheumatoid arthritis treated with d-penicillamine. J Am Acad Dermatol. 1986;14(4):681.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"22_CR133","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archopht.1989.01070020181008","volume":"107","author":"T Marti-Huguet","year":"1989","unstructured":"Marti-Huguet T, Quintana M, Cabiro I. Cicatricial pemphigoid associated with d-penicillamine treatment. Arch Ophthalmol. 1989;107(8):1115.","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"22_CR134","first-page":"484","volume":"77","author":"P Rimbaud","year":"1970","unstructured":"Rimbaud P, Mirouze J, Mary P, et al. Syndrome of \u201cepidermolysis bullosa with epidermal cyst\u201d appearing during Wilson\u2019s disease treated with penicillamine. Bull Soc Fr Dermatol Syphiligr. 1970;77(4):484\u20136.","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"issue":"2","key":"22_CR135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2133.1967.tb11471.x","volume":"79","author":"WE Beer","year":"1967","unstructured":"Beer WE, Cooke KB. Epidermolysis bullosa induced by penicillamine. Br J Dermatol. 1967;79(2):123\u20135.","journal-title":"Br J Dermatol"},{"key":"22_CR136","doi-asserted-by":"crossref","unstructured":"Godar JM, Norins AL. Vesicular lesions in a woman with progressive systemic sclerosis: penicillamine-induced intradermal vesicles: an example of human lathyrism. Arch Dermatol. 1992;128(7):977\u20138, 980\u20131.","DOI":"10.1001\/archderm.128.7.977b"},{"key":"22_CR137","unstructured":"Walshe JM. Toxic reactions to penicillamine in patients with Wilson\u2019s disease. Postgrad Med J. 1968;Suppl:6\u20138."},{"key":"22_CR138","unstructured":"Camus JP, Homberg JC, Crouzet J, et al. Autoantibody formation in d-penicillamine-treated rheumatoid arthritis. J Rheumatol Suppl. 1981;7:80\u20133."},{"issue":"4","key":"22_CR139","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jama.1972.03200040100036","volume":"220","author":"I Oliver","year":"1972","unstructured":"Oliver I, Liberman UA, DeVries A. Lupus-like syndrome induced by penicillamine in cystinuria. JAMA. 1972;220(4):588.","journal-title":"JAMA"},{"key":"22_CR140","unstructured":"Walshe JM. Penicillamine and the SLE syndrome. J Rheumatol Suppl. 1981;7:155\u201360."},{"key":"22_CR141","unstructured":"Sternlieb I, Fisher M, Scheinberg IH. Penicillamine-induced skin lesions. J Rheumatol Suppl. 1981;7:149\u201354."},{"issue":"6","key":"22_CR142","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2340\/0001555559543544","volume":"59","author":"NB Simpson","year":"1979","unstructured":"Simpson NB, Golding JR. Dermatomyositis induced by penicillamine. Acta Derm Venereol. 1979;59(6):543\u20134.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"22_CR143","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/03009747809098847","volume":"7","author":"J Petersen","year":"1978","unstructured":"Petersen J, Halberg P, Hojgaard K, et al. Penicillamine-induced polymyositis\u2013dermatomyositis. Scand J Rheumatol. 1978;7(2):113\u20137.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"22_CR144","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/ard.36.1.94","volume":"36","author":"L Fernandes","year":"1977","unstructured":"Fernandes L, Swinson DR, Hamilton EB. Dermatomyositis complicating penicillamine treatment. Ann Rheum Dis. 1977;36(1):94\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"22_CR145","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archneur.1972.00490170088013","volume":"27","author":"PL Schraeder","year":"1972","unstructured":"Schraeder PL, Peters HA, Dahl DS. Polymyositis and penicillamine. Arch Neurol. 1972;27(5):456\u20137.","journal-title":"Arch Neurol"},{"issue":"6","key":"22_CR146","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000251461","volume":"150","author":"WJ Staak van de","year":"1975","unstructured":"van de Staak WJ, Cotton DW, Jonckheer-Venneste MM, et al. Lichenoid eruption following penicillamine: a case report with some biochemical observations. Dermatologica. 1975;150(6):372\u20134.","journal-title":"Dermatologica"},{"issue":"3","key":"22_CR147","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archderm.1981.01650030018010","volume":"117","author":"JR Seehafer","year":"1981","unstructured":"Seehafer JR, Rogers RS, Fleming CR, et al. Lichen planus-like lesions caused by penicillamine in primary biliary cirrhosis. Arch Dermatol. 1981;117(3):140\u20132.","journal-title":"Arch Dermatol"},{"issue":"3","key":"22_CR148","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archinte.1967.00300030116024","volume":"120","author":"RA Bennett","year":"1967","unstructured":"Bennett RA, Harbilas E. Wilson\u2019s disease with aseptic meningitis and penicillamine-related cheilosis. Arch Intern Med. 1967;120(3):374\u20136.","journal-title":"Arch Intern Med"},{"issue":"1","key":"22_CR149","first-page":"3","volume":"2","author":"P Rimbaud","year":"1973","unstructured":"Rimbaud P, Mirouze J, Mary P, et al. Dermatological complications during treatment of Wilsons disease with d-penicillamine. Med Chir Dig. 1973;2(1):3\u20138.","journal-title":"Med Chir Dig"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0022-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-013-0022-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-013-0022-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T08:09:42Z","timestamp":1715242182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-013-0022-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,20]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s40257-013-0022-z","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,20]]}}}